Tapewire

NYSE · USD

INSP

Inspire Medical Systems, Inc.

Export transactions ↓
Tapewire entity
1186
SEC CIK
0001609550
Parsed reports
589

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2026 Filed Feb 11, 2026 22:20 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 968 $66.33 $64,207.44
Disclosure

SEC source: 0001104659-26-013528 · tm266005-3_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,321

F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

F2 · balance_after: Includes (i) 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 27 shares acquired under the Plan on December 31, 2025.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:17 UTC
Buchholz RichardInterim CFO
Tax withholdingCommon Stock 327 $66.33 $21,689.91
Disclosure

SEC source: 0001104659-26-013512 · tm266005-6_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,567

F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

F2 · balance_after: Includes 27 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025.

Read SEC document
January 15, 2026 Filed Jan 20, 2026 21:06 UTC GrantCommon Stock 180 $96.47 $17,364.60
Disclosure

SEC source: 0001104659-26-005032 · tm263634-3_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,166

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2026 Filed Jan 20, 2026 21:06 UTC GrantCommon Stock 304 $96.47 $29,326.88
Disclosure

SEC source: 0001104659-26-005034 · tm263634-4_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,758

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2026 Filed Jan 20, 2026 21:05 UTC GrantCommon Stock 200 $96.47 $19,294.00
Disclosure

SEC source: 0001104659-26-005030 · tm263634-2_4seq1.xml · nonDerivative · entry 1

Broader Shelley G · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,567

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2026 Filed Jan 20, 2026 21:05 UTC GrantCommon Stock 181 $96.47 $17,461.07
Disclosure

SEC source: 0001104659-26-005027 · tm263634-1_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,416

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 09, 2026 Filed Jan 12, 2026 21:05 UTC
Rondoni JohnSee Remarks
SaleCommon Stock 109 $100.00 $10,900.00
Disclosure

SEC source: 0001104659-26-002864 · tm262949-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,797

F1 · balance_after: Includes 140 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated May 21, 2025.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:05 UTC SaleCommon Stock 1,200 $139.00 $166,800.00
Disclosure

SEC source: 0001104659-25-118455 · tm2532785-1_4seq1.xml · nonDerivative · entry 1

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,846

Read SEC document
November 28, 2025 Filed Dec 1, 2025 22:56 UTC SaleCommon Stock 2,000 $127.48 $254,960.00
Disclosure

SEC source: 0001104659-25-117422 · tm2532514-1_4seq1.xml · nonDerivative · entry 1

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,046

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:16 UTC GrantCommon Stock 229 $78.84 $18,054.36
Disclosure

SEC source: 0001104659-25-100096 · tm2528856-4_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,986

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:15 UTC GrantCommon Stock 372 $78.84 $29,328.48
Disclosure

SEC source: 0001104659-25-100093 · tm2528856-2_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,454

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:15 UTC GrantCommon Stock 221 $78.84 $17,423.64
Disclosure

SEC source: 0001104659-25-100095 · tm2528856-3_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,235

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:15 UTC GrantCommon Stock 245 $78.84 $19,315.80
Disclosure

SEC source: 0001104659-25-100089 · tm2528856-1_4seq1.xml · nonDerivative · entry 1

Broader Shelley G · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,367

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
August 29, 2025 Filed Sep 3, 2025 00:14 UTC
Buchholz RichardChief Financial Officer
SaleCommon Stock 11,000 $93.39 $1,027,290.00
Disclosure

SEC source: 0001104659-25-086559 · tm2525085-1_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,867

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,159 $0.00 Strike: $42.15 $0.00
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · derivative · entry 11

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,159 shares

Expires 2028-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 17,849 $0.00 Strike: $71.00 $0.00
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · derivative · entry 10

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,849 shares

Expires 2029-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Tax withholdingCommon Stock 276 $90.28 $24,917.28
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 5

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,867

F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Tax withholdingCommon Stock 2,455 $90.21 $221,465.55
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 4

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,143

F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Tax withholdingCommon Stock 2,649 $90.24 $239,045.76
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 3

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,598

F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Exercise / conversionCommon Stock 7,159 $42.15 $301,751.85
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 2

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,247

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 20:05 UTC
Buchholz RichardChief Financial Officer
Exercise / conversionCommon Stock 17,849 $71.00 $1,267,279.00
Disclosure

SEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,088

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on June 30, 2025.

Read SEC document
August 08, 2025 Filed Nov 25, 2025 01:40 UTC
Curet MyriamDirector
SaleCommon Stock 4 $77.28 $309.10
Disclosure

SEC source: 0001104659-25-115560 · tm2529996-1_4seq1.xml · nonDerivative · entry 4

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,365

F1 · kind: These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.

Read SEC document
July 31, 2025 Filed Aug 5, 2026 00:25 UTC
Mann MelissaChief People Officer
Tax withholdingCommon Stock 326 $124.54 $40,600.04
Disclosure

SEC source: 0001104659-26-090595 · tm2622257-1_4seq1.xml · nonDerivative · entry 1

Mann Melissa · CIK 0002031034 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,283

F1 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC GrantCommon Stock 131 $128.00 $16,768.00
Disclosure

SEC source: 0001104659-25-068325 · tm2521079-1_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,757

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:08 UTC GrantCommon Stock 221 $128.00 $28,288.00
Disclosure

SEC source: 0001104659-25-068329 · tm2521079-4_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,082

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:07 UTC GrantCommon Stock 133 $128.00 $17,024.00
Disclosure

SEC source: 0001104659-25-068328 · tm2521079-3_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,014

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:06 UTC GrantCommon Stock 148 $128.00 $18,944.00
Disclosure

SEC source: 0001104659-25-068327 · tm2521079-2_4seq1.xml · nonDerivative · entry 1

Broader Shelley G · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,122

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 22:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001104659-25-057436 · tm2517412-1_4seq1.xml · derivative · entry 3

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,296

Underlying: Common Stock · 4,000 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 22:06 UTC Exercise / conversionCommon Stock 4,000 $16.00 $64,000.00
Disclosure

SEC source: 0001104659-25-057436 · tm2517412-1_4seq1.xml · nonDerivative · entry 1

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option is fully vested and exercisable.

Read SEC document
May 19, 2025 Filed May 21, 2025 20:05 UTC
Rondoni JohnSee Remarks
SaleCommon Stock 1,734 $149.38 $259,024.92
Disclosure

SEC source: 0001104659-25-051603 · tm2515858-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,766

Read SEC document
May 08, 2025 Filed Nov 25, 2025 01:40 UTC
Curet MyriamDirector
SaleCommon Stock 2 $153.22 $306.45
Disclosure

SEC source: 0001104659-25-115560 · tm2529996-1_4seq1.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,369

F1 · kind: These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.

F2 · shares: The Reporting Person's sale of common stock on May 8, 2025 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1 share at a price per share of $153.2237, with the Reporting Person's purchase of 1 share of common stock at a price per share of $148.262 on April 7, 2025. Dr. Curet paid to the Issuer $4.97, representing the full amount of the profit realized in connection with the short-swing transaction.

Read SEC document
May 02, 2025 Filed May 5, 2025 23:27 UTC Tax withholdingCommon Stock 35 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044670 · tm2514079-4_4seq1.xml · nonDerivative · entry 2

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,626

F2 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on May 2, 2024.

Read SEC document
May 02, 2025 Filed May 5, 2025 23:31 UTC SaleCommon Stock 360 $160.00 $57,600.00
Disclosure

SEC source: 0001104659-25-044673 · tm2514079-7_4seq1.xml · nonDerivative · entry 2

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,046

Read SEC document
May 01, 2025 Filed May 5, 2025 23:23 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044666 · tm2514079-1_4seq1.xml · nonDerivative · entry 1

Burks Cynthia · CIK 0001941449 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,651

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:27 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044670 · tm2514079-4_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,661

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:32 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044674 · tm2514079-8_4seq1.xml · nonDerivative · entry 1

Broader Shelley G · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,974

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 6, 2025 00:26 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044697 · tm2514079-6_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,861

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:31 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044673 · tm2514079-7_4seq1.xml · nonDerivative · entry 1

mcCormick Shawn · CIK 0001454092 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,406

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:29 UTC
Curet MyriamDirector
GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044672 · tm2514079-5_4seq1.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,366

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:26 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044669 · tm2514079-3_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,881

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
May 01, 2025 Filed May 5, 2025 23:25 UTC GrantCommon Stock 1,266 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-044667 · tm2514079-2_4seq1.xml · nonDerivative · entry 1

Mead Dana G Jr. · CIK 0001222358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,651

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Read SEC document
April 14, 2025 Filed Apr 16, 2025 20:06 UTC GrantCommon Stock 102 $149.70 $15,269.40
Disclosure

SEC source: 0001104659-25-035495 · tm2512484-2_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,395

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
April 14, 2025 Filed Apr 16, 2025 20:07 UTC GrantCommon Stock 169 $149.70 $25,299.30
Disclosure

SEC source: 0001104659-25-035497 · tm2512484-3_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,595

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
April 14, 2025 Filed Apr 16, 2025 20:08 UTC GrantCommon Stock 103 $149.70 $15,419.10
Disclosure

SEC source: 0001104659-25-035499 · tm2512484-4_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,615

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
April 14, 2025 Filed Apr 16, 2025 20:05 UTC GrantCommon Stock 116 $149.70 $17,365.20
Disclosure

SEC source: 0001104659-25-035493 · tm2512484-1_4seq1.xml · nonDerivative · entry 1

Broader Shelley G · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,708

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
April 07, 2025 Filed Nov 25, 2025 01:40 UTC
Curet MyriamDirector
PurchaseCommon Stock 1 $148.26 $148.26
Disclosure

SEC source: 0001104659-25-115560 · tm2529996-1_4seq1.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,371

F1 · kind: These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.

Read SEC document
March 20, 2025 Filed Nov 25, 2025 01:40 UTC
Curet MyriamDirector
PurchaseCommon Stock 4 $163.84 $655.36
Disclosure

SEC source: 0001104659-25-115560 · tm2529996-1_4seq1.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,370

F1 · kind: These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:46 UTC
Rondoni JohnChief Technology Officer
SaleCommon Stock 2,287 $185.60 $424,467.20
Disclosure

SEC source: 0001104659-25-020914 · tm258354-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,500

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:47 UTC
Ban RandySee Remarks
SaleCommon Stock 478 $187.08 $89,424.29
Disclosure

SEC source: 0001104659-25-020916 · tm258354-2_4seq1.xml · nonDerivative · entry 3

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,259

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:47 UTC
Ban RandySee Remarks
SaleCommon Stock 1,233 $186.20 $229,586.57
Disclosure

SEC source: 0001104659-25-020916 · tm258354-2_4seq1.xml · nonDerivative · entry 2

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,737

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.